Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease. | ClinicLens
The effect of adjunctive glucocorticoids in the primary treatment of Kawasaki disease in unselected patients remains unknown. In this multicenter, open-label, randomized, controlled trial in China, we assigned participants with newly diagnosed Kawasaki disease in a 1:1 ratio to r
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.